These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34137386)

  • 1. LONGITUDINAL FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY ANALYSIS IN PATIENTS WITH MACULAR TELANGIECTASIA TYPE 2 (MacTel).
    Sauer L; Vitale AS; Modersitzki NK; Bernstein PS
    Retina; 2021 Jul; 41(7):1416-1427. PubMed ID: 34137386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY (FLIO) PATTERNS IN CLINICALLY UNAFFECTED CHILDREN OF MACULAR TELANGIECTASIA TYPE 2 (MACTEL) PATIENTS.
    Sauer L; Vitale AS; Andersen KM; Hart B; Bernstein PS
    Retina; 2020 Apr; 40(4):695-704. PubMed ID: 31517727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FLUORESCENCE LIFETIME PATTERNS IN MACULAR TELANGIECTASIA TYPE 2.
    Solberg Y; Dysli C; Wolf S; Zinkernagel MS
    Retina; 2020 Jan; 40(1):99-108. PubMed ID: 30664123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence lifetime imaging ophthalmoscopy: autofluorescence imaging and beyond.
    Sauer L; Vitale AS; Modersitzki NK; Bernstein PS
    Eye (Lond); 2021 Jan; 35(1):93-109. PubMed ID: 33268846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) of Macular Pigment.
    Sauer L; Andersen KM; Li B; Gensure RH; Hammer M; Bernstein PS
    Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3094-3103. PubMed ID: 30025128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of Hydroxychloroquine Toxicity with Fluorescence Lifetime Imaging Ophthalmoscopy.
    Sauer L; Calvo CM; Vitale AS; Henrie N; Milliken CM; Bernstein PS
    Ophthalmol Retina; 2019 Oct; 3(10):814-825. PubMed ID: 31345727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY IN PATIENTS WITH MACULAR TELANGIECTASIA TYPE 2 WITH AND WITHOUT DIABETES.
    Sauer L; Vitale AS; Jacoby RS; Hart B; Bernstein PS
    Retina; 2023 Sep; 43(9):1597-1607. PubMed ID: 37263186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RETINAL FLECKS IN STARGARDT DISEASE REVEAL CHARACTERISTIC FLUORESCENCE LIFETIME TRANSITION OVER TIME.
    Solberg Y; Dysli C; Escher P; Berger L; Wolf S; Zinkernagel MS
    Retina; 2019 May; 39(5):879-888. PubMed ID: 30985551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) in Patients with Choroideremia.
    Vitale AS; Sauer L; Modersitzki NK; Bernstein PS
    Transl Vis Sci Technol; 2020 Sep; 9(10):33. PubMed ID: 33062396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autofluorescence Lifetimes Measured with Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) Are Affected by Age, but Not by Pigmentation or Gender.
    Sauer L; Vitale AS; Milliken CM; Modersitzki NK; Blount JD; Bernstein PS
    Transl Vis Sci Technol; 2020 Aug; 9(9):2. PubMed ID: 32879759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive Dysmorphia of Retinal Pigment Epithelium in Age-Related Macular Degeneration Investigated by Fluorescence Lifetime Imaging.
    Hammer M; Jakob-Girbig J; Schwanengel L; Curcio CA; Hasan S; Meller D; Schultz R
    Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):2. PubMed ID: 34491262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring foveal sparing in geographic atrophy with fluorescence lifetime imaging ophthalmoscopy - a novel approach.
    Sauer L; Klemm M; Peters S; Schweitzer D; Schmidt J; Kreilkamp L; Ramm L; Meller D; Hammer M
    Acta Ophthalmol; 2018 May; 96(3):257-266. PubMed ID: 29105362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fundus Autofluorescence Lifetime Patterns in Retinitis Pigmentosa.
    Dysli C; Schuerch K; Escher P; Wolf S; Zinkernagel MS
    Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):1769-1778. PubMed ID: 29610860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence Lifetime Imaging in Stargardt Disease: Potential Marker for Disease Progression.
    Dysli C; Wolf S; Hatz K; Zinkernagel MS
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):832-41. PubMed ID: 26934141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of clinical approaches in fluorescence lifetime imaging ophthalmoscopy.
    Sauer L; Andersen KM; Dysli C; Zinkernagel MS; Bernstein PS; Hammer M
    J Biomed Opt; 2018 Sep; 23(9):1-20. PubMed ID: 30182580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence Lifetime Imaging Ophthalmoscopy: A Novel Way to Assess Macular Telangiectasia Type 2.
    Sauer L; Gensure RH; Hammer M; Bernstein PS
    Ophthalmol Retina; 2018 Jun; 2(6):587-598. PubMed ID: 30116796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence lifetime imaging of the ocular fundus in mice.
    Dysli C; Dysli M; Enzmann V; Wolf S; Zinkernagel MS
    Invest Ophthalmol Vis Sci; 2014 Sep; 55(11):7206-15. PubMed ID: 25249601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring macular pigment changes in macular holes using fluorescence lifetime imaging ophthalmoscopy.
    Sauer L; Peters S; Schmidt J; Schweitzer D; Klemm M; Ramm L; Augsten R; Hammer M
    Acta Ophthalmol; 2017 Aug; 95(5):481-492. PubMed ID: 27775222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autofluorescence Lifetimes in Geographic Atrophy in Patients With Age-Related Macular Degeneration.
    Dysli C; Wolf S; Zinkernagel MS
    Invest Ophthalmol Vis Sci; 2016 May; 57(6):2479-87. PubMed ID: 27149697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FUNDUS AUTOFLUORESCENCE LIFETIMES AND CENTRAL SEROUS CHORIORETINOPATHY.
    Dysli C; Berger L; Wolf S; Zinkernagel MS
    Retina; 2017 Nov; 37(11):2151-2161. PubMed ID: 28099314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.